Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophagogastric Cancer × Cisplatin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 153 Esophageal Neoplasms 147 Esophageal Squamous Cell Carcinoma 101 Pancreatic Neoplasms 70 Biliary Tract Neoplasms 65 Cholangiocarcinoma 64 Adenocarcinoma Of Esophagus 48 Gallbladder Neoplasms 36 Colorectal Neoplasms 33 Carcinoma, Non-Small-Cell Lung 28 Neoplasm Metastasis 26 Neoplasms 25 Carcinoma, Hepatocellular 25 Bile Duct Neoplasms 23 Ovarian Neoplasms 18 Liver Neoplasms 16 Colonic Neoplasms 12 Peritoneal Neoplasms 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Gastrointestinal Neoplasms 11 Anus Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Adenocarcinoma 10 Melanoma 9 Carcinoma, Squamous Cell 9 Rectal Neoplasms 8 Lung Neoplasms 8 Hepatoblastoma 8 Breast Neoplasms 8 Sarcoma 7

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡